| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 947.61B | 916.71B | 950.29B | 864.72B | 760.72B |
| Gross Profit | 111.48B | 96.67B | 106.67B | 95.83B | 96.05B |
| EBITDA | 98.14B | 108.89B | 104.04B | 91.32B | 97.76B |
| Net Income | 16.54B | 46.24B | 40.88B | 29.66B | 38.34B |
Balance Sheet | |||||
| Total Assets | 906.20B | 889.95B | 965.60B | 905.91B | 855.24B |
| Cash, Cash Equivalents and Short-Term Investments | 274.52B | 276.15B | 302.87B | 315.04B | 323.94B |
| Total Debt | 1.92B | 10.38B | 18.77B | 27.46B | 25.22B |
| Total Liabilities | 230.11B | 210.08B | 246.32B | 235.40B | 227.92B |
| Stockholders Equity | 616.83B | 627.20B | 671.93B | 628.83B | 591.16B |
Cash Flow | |||||
| Free Cash Flow | 45.36B | 39.16B | 59.05B | 19.93B | 36.77B |
| Operating Cash Flow | 99.91B | 88.36B | 96.37B | 59.76B | 65.71B |
| Investing Cash Flow | -10.84B | -40.99B | -50.16B | -71.54B | -52.15B |
| Financing Cash Flow | -71.43B | -78.35B | -59.68B | -13.28B | -8.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥51.69B | 8.17 | 8.46% | 2.64% | -3.94% | 36.68% | |
75 Outperform | ¥435.35B | 14.01 | 6.37% | 2.88% | 1.74% | 19.10% | |
74 Outperform | ¥554.02B | 9.48 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥154.79B | 18.60 | ― | 2.93% | 3.63% | 35.38% | |
70 Outperform | ¥773.07B | 48.05 | 7.20% | 2.41% | 3.37% | -62.36% | |
68 Neutral | ¥5.19T | 11.64 | 6.98% | 2.98% | 5.28% | 12.66% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |